Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Falling foreign exchange reserves and US-Iran negotiations put pressure on the rand, with inflation risks becoming the focus.

Falling foreign exchange reserves and US-Iran negotiations put pressure on the rand, with inflation risks becoming the focus.

汇通财经汇通财经2026/06/05 13:52
Show original
  1. The South African rand weakened on Friday, trading at 16.40 to the US dollar in intraday trading, down about 0.5% from the previous day's close, as the domestic market digested last month’s decline in foreign exchange reserves. Meanwhile, peace talks between the US and Iran kept market sentiment cautious, and concerns about inflation remained in focus.
  2. Data from the South African Reserve Bank shows that by the end of May, international liquidity reserves had fallen to $73.47 billion from $73.76 billion in April. As a net fuel importer, South Africa is highly exposed to the risks posed by rising global energy prices.
  3. Next week, investors will focus on Tuesday’s GDP data release to gauge the health of Africa's largest economy. Current account, mining, and manufacturing data will be announced on Thursday. The Johannesburg Stock Exchange Top-40 Index fell 0.6%, and the yield on the benchmark 2035 government bond rose 13 basis points to 8.68%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage